This hypothesis is supported by our finding that neutralization of circulating IL-1β in CKD mice reduced atrial IL-1β levels, impeded the development of atrial fibrosis and atrial enlargement, and prevented the inducibility of AF in CKD. The gene discussed is IL1B; the disease is chronic kidney disease.